Jonathan Barratt

Jonathan Barratt

His research is focussed on a bench to bedside approach to improving our understanding of the pathogenesis of IgA nephropathy a common global cause of kidney failure. Jonathan is the IgA nephropathy Rare Disease Group lead for the UK National Registry of Rare Kidney Diseases (RaDaR) and a member of the steering committee for the […]

Read More

September 29th, 2020

Dipti Talaulikar

Associate Professor Dipti Talaulikar is a Senior Consultant in Clinical and Laboratory Hematology at Canberra Hospital and Associate Professor at the Australian National University (ANU). She is also a long-standing member of Myeloma Australia’s Medical and Scientific Advisor Group, as well as other leading cancer trial and research groups. She is dedicated to improving patient […]

Read More

August 13th, 2020

Dr. Daniel Weiner

Dr. Daniel Weiner is a graduate of Tufts University School of Medicine has completed a Masters Degree Program in Clinical Care Research at the Graduate School of Biomedical Sciences. He is a nephrologist at Tufts Medical Center and an Associate Professor of Medicine at Tufts University School of Medicine. His research interests focus on the […]

Read More

August 8th, 2020

Dr. Stephen Seliger

Dr. Stephen Seliger received his medical education from New York University School of Medicine and his Master’s of Science in Epidemiology from the University Of Washington School Of Public Health. He is an Associate Professor in the Department of Medicine, Division of Nephrology at the University of Maryland School of Medicine. His research interests relate […]

Read More

August 8th, 2020

Daniel (Yanhe) Wang, MD, PhD

Daniel (Yanhe) Wang, MD, PhD Head of Biostatistics, George Clinical Daniel is the Head of Biostatistics at George Clinical, MD and PhD of Fudan University, and he was an associate researcher at the Chinese CDC. He has nine publications and more than fifteen years’ work experience in biostatistics. Daniel has experience in leading, reviewing and […]

Read More

March 11th, 2020

Glenn Kerkhof, BCom, MBA

Glenn Kerkhof is Executive Chairman of George Clinical. Glenn has over 27 years’ experience in the contract research or drug development industry and joined George Clinical from Chiltern, where he was Chief Executive Officer. Before Chiltern, Glenn served as Vice President, Clinical Services for Charles River Laboratories, and as Vice President, Clinical Europe for Inveresk […]

Read More

June 27th, 2018

Scott Featherston

Scott is the Chief Financial Officer & Director, Corporate Development for George Health Enterprises, the company that holds George Clinical.  Scott was formerly the Global Health Sector Lead and a Principal Investment Officer for the International Finance Corporation, the private sector arm of the World Bank Group. During his time at IFC, Scott led numerous […]

Read More

May 29th, 2019

James Cheong, BSc (Pharm), MBA

James Cheong is Chief Executive Officer of George Clinical. James has significant business leadership experience and more than 20 years of industry experience in both global pharma and CRO companies in the areas of Clinical Operations, Regulatory Affairs, Data Science and Regional Management. Prior to George Clinical, Cheong served as Head of Clinical Operations for […]

Read More

January 24th, 2019

Sean Hart

As Chief Business Office for George Clinical, Sean Hart leads the U.S. and Asia-Pacific business development teams and directs global marketing and public relations efforts for George Clinical. Prior to joining George Clinical, Sean was the Executive Vice President and Managing Director of Vector Oncology overseeing the Global Pharma Services team including early phase and […]

Read More

June 27th, 2018

Maria Ali, MBBS, MBA

Maria serves as the Chief Medical Officer for George Clinical, responsible for continuing to build the organization’s enviable network of investigators and scientific leaders. Previously, she led the medical and safety services group at George Clinical who provide safety management, endpoint adjudication, medical monitoring and scientific leadership for both commercially sponsored and academic clinical trials. […]

Read More

June 27th, 2018

Amanda Kelly Gill

Amanda Kelly Gill MPH, BN (Hons), is Regional Head, Project Operations, APAC at George Clinical, and is based in Sydney Australia.  Amanda is responsible for the project management and clinical operations teams working on components of global registration and investigator-initiated studies across the region. With over 20 years in the industry, Amanda has extensive experience […]

Read More

September 4th, 2020

Zhenfei Yin

As Country Head and Regional Head of Project Operations, China, Zhenfei is responsible for leading the operations teams across China. Zhenfei Yin brings with him more than 14 years of substantial industry experience leading Clinical Operations, Project Management, and Business Development teams across the CRO and Pharmaceutical sectors, including experience in Electronic Data Capture trials. […]

Read More

July 29th, 2020

Susan Cole

Susan is responsible for U.S. project and clinical operations including project management, study startup, monitoring and site management services. With over 25 years in clinical research, she brings experience in all phases of clinical trials, multiple therapeutic areas including over 12 years in oncology, and key leadership roles in clinical operations and financial management. She […]

Read More

September 4th, 2020

Amanda Jubb, BSc (Hons)

Amanda is responsible for the project management and clinical operations teams to deliver George Clinical’s studies to the highest standards. Amanda has over 25 years’ experience implementing clinical trials across the Asia-Pacific region and more than 20 years’ line management experience. Amanda has worked across all clinical trial phases and George Clinical’s therapy areas. Her […]

Read More

June 27th, 2018

Abby Abraham

Abby Abraham serves as the Global Head of Data Science for George Clinical. Abby is responsible for developing new capabilities in data science and operations and enabling continued growth of Data management in the organization. He brings a combination of significant experience in clinical operations, leveraging data for operational effectiveness, and adopting new technologies to […]

Read More

July 29th, 2020

Louise Brnabic, PhD

Louise Brnabic, Global Head, Quality, and is responsible for providing quality management support for all functional areas and countries, ensuring that global standards are maintained in all clinical trial-related activities. With a background in biochemical research, Louise has 20 years’ experience in quality management, project management, and clinical operations. She has worked with pharmaceutical and […]

Read More

June 23rd, 2020

Jacqueline Thorn, PhD, MBA, GDip. IP

Jacqueline is responsible for global corporate and commercial functions which includes oversight of legal and contracting activities, insurance, risk management, corporate compliance, knowledge management and external vendor solutions. Jacqueline is also responsible for oversight of the offices in Asia and Europe and Country Head for Australia and New Zealand. Jacqueline has extensive experience in business […]

Read More

June 27th, 2018

Harmony Chan, MBA

Harmony leads the Human Resources (HR) team globally to effectively partner with the organization to deliver on its people and company objectives.  Harmony has over 10 years of talent acquisition and generalist HR experience across the Life Sciences, IT&T and Built Environment industries globally and is MBA qualified in addition to holding a BA (Organizational […]

Read More

September 29th, 2018

Professor Hiddo Lambers Heerspink

Hiddo Lambers Heerspink is affiliated with the Department of Clinical Pharmacy and Pharmacology of the University Medical Center Groningen, the Netherlands. He received his PhD from the medical faculty of the University Medical Center Groningen in 2008. He then worked as a post-doctoral fellow at The George Institute in Sydney, Australia where he investigated the […]

Read More

May 16th, 2019

Jessie Poon MMsc, BHS

Jessie is responsible for leading the East Asia project management and clinical operations teams across East Asia countries including Hong Kong, Malaysia, South Korea, Taiwan, Thailand, Indonesia, Vietnam, and Philippines.  She has over 15 years’ experience working in the pharmaceutical and clinical research industry in various fields including project management and global studies. In addition, […]

Read More

June 27th, 2018

Professor Mark Huffman

Mark Huffman is the Quentin D. Young Professor of Health Policy and Associate Professor of Preventive Medicine and Medicine-Cardiology at Northwestern University’s Feinberg School of Medicine and director of the Center for Global Cardiovascular Health within the Institute for Global Health at Northwestern. He has a secondary appointment as an Associate Professor of Food Policy […]

Read More

February 7th, 2019

Professor Carolyn Lam

Professor Lam is a Senior Consultant of the National Heart Centre, Singapore and Professor of Duke-NUS Cardiovascular Academic Clinical Program. Dr Lam’s clinical sub-specialty is heart failure, and she is recognized globally for her expertise in heart failure with preserved ejection fraction. She also has expertise in women’s cardiovascular disease, hemodynamics, echocardiography, biomarkers and clinical […]

Read More

February 7th, 2019

Dr. Mikhail Kosiborod

Dr. Mikhail Kosiborod is a cardiologist, Vice President of Research at Saint Luke’s Health System, Director of Cardiometabolic Research and the Haverty Cardiometabolic Center of Excellence at Saint Luke’s Mid America Heart Institute, and Professor of Medicine at the University of Missouri-Kansas City. He received training in clinical research, epidemiology and health policy through the […]

Read More

February 7th, 2019

Candice Delcourt

Candice Delcourt is a neurologist specializing in stroke medicine. She is a Senior Research Fellow at The George Institute in Sydney and the Hunter Stroke Service in Newcastle. She is a Senior Clinical Lecturer at the University of Sydney. She holds a clinical appointment at the Royal Prince Alfred Hospital. She obtained her specialist medical […]

Read More

June 27th, 2018

Professor Mark Woodward

Working in the Professorial Advisory Unit of The George Institute, Mark is also a Professor of Medical Statistics in the Faculty of Medicine, UNSW Sydney, Professor of Statistics and Epidemiology at the University of Oxford, where he is an Oxford Martin Senior Fellow and Adjunct Professor of Epidemiology at Johns Hopkins University. He is the […]

Read More

June 27th, 2018

Professor Stephen Jan

Stephen Jan is Head of the Health Economics and Process Evaluation Program at the George Institute for Global Health and Professor, Faculty of Medicine, UNSW Sydney. He is an Honorary Professor at the University of Sydney, a Director of the Sax Institute and an Associate at both the Menzies Centre for Health Policy and the […]

Read More

June 27th, 2018

Associate Professor Laurent Billot

Laurent is a senior biostatistician with 20 years of experience in health research. He is Director of the Statistics Division at the George Institute for Global Health and Associate Professor, Faculty of Medicine, UNSW Sydney. He is responsible for providing statistical services to the George Institute and its collaborators in Australia and globally. He holds […]

Read More

June 27th, 2018

Professor John Chalmers, AC

John Chalmers AC FAA has an outstanding record in hypertension research, both fundamental and clinical. His groundbreaking research on the role of the brain in the development of hypertension led to his election to Fellowship of the Australian Academy of Science and helped establish Flinders University as a leading international centre in hypertension and neuroscience […]

Read More

June 27th, 2018

Dr. Muh Geot Wong

Dr. Wong is Renal Physician at the Royal North Shore hospital, Sydney, Australia. He is also a senior research fellow at the George Institute of Global Health and holds a Senior Lecturer position, Faculty of Medicine, UNSW Sydney. His PhD entitled “Novel therapeutic options in models of nephropathy” was awarded in 2011. His main area […]

Read More

June 27th, 2018

Associate Professor Martin Gallagher

Martin holds positions as Associate Professor, Faculty of Medicine, UNSW Sydney, Associate Professor of Medicine at Concord Hospital Clinical School (part of the Sydney Medical School), Director of the Renal and Metabolic Division in the George Institute and a clinical nephrologist in the Renal Dept. at Concord Repatriation and General Hospital. He works extensively in […]

Read More

June 27th, 2018

Professor Anthony Rodgers

Anthony Rodgers is a Professor of Global Health at The George Institute. After graduating in medicine in the United Kingdom he trained in epidemiology and public health in New Zealand. He was the Principal Author of the 2002 World Health Report, the main annual publication for WHO. Since 2003 he has led a public-private partnership […]

Read More

June 27th, 2018

Professor Kazem Rahimi

Kazem Rahimi is the James Martin Senior Fellow in Essential Healthcare at the University of Oxford and Honorary Consultant Cardiologist at the John Radcliffe Hospital, Oxford. As the Deputy Director of The George Institute UK he leads the Essential Healthcare Programme, which aims to find practical and affordable solutions for the global health priorities of […]

Read More

June 27th, 2018

Professor Vivekanand Jha

Professor Vivekanand Jha is the Executive Director, The George Institute for Global Health, India, and James Martin Fellow at The George Institute for Global Health at the University of Oxford. Prior to joining The George Institute, he was Professor of Nephrology and Head, Department of Translational Regenerative Medicine and Officer-In-Charge, Medical Education and Research Cell […]

Read More

June 27th, 2018

Professor John Myburgh, AO

Professor John A Myburgh AO, is Professor of Intensive Care Medicine, UNSW Sydney; Director of the Division of Critical Care and Trauma at the George Institute for International Health and Senior Intensive Care Physician at the St George Hospital, Sydney. He holds honorary Professorial appointments at the University of Sydney and Monash University School of […]

Read More

June 27th, 2018

Professor Simon Finfer

Simon Finfer is a Professorial Fellow in the Critical Care and Trauma Division at The George Institute for Global Health. He is a practicing critical care physician with an appointment as a Senior Staff Specialist at Royal North Shore Hospital and Director of Intensive Care at the Sydney Adventist Hospital, the largest not-for-profit hospital in […]

Read More

June 27th, 2018

Professor Craig Anderson

Professor Craig Anderson is Professor of Neurology and Epidemiology, Faculty of Medicine, UNSW Sydney, and is in part-time clinical practice as a neurologist at Royal Prince Alfred Hospital, Sydney, Australia. He is Executive Director of The George Institute, China and based with the team at Peking University Health Science Center in Beijing, China. Craig holds […]

Read More

June 27th, 2018

Professor Christine Jenkins

Christine Jenkins is Head of the Respiratory Group at The George Institute for Global Health; Senior Staff Specialist in Thoracic Medicine at Concord Hospital, Sydney; Clinical Professor and Head of Respiratory Discipline at the University of Sydney; and Professor of Respiratory Medicine at UNSW Sydney. Christine has been principal investigator and has led many investigator-initiated […]

Read More

June 27th, 2018

Associate Professor Meg Jardine

A/Prof Meg Jardine is a clinician researcher developing a program of research exploring the cardiovascular and other complications of chronic kidney disease and diabetes. Dr. Jardine has worked as a Nephrologist in both the public and private sectors, where she directly manages chronic kidney disease and diabetes and their consequences for patients. She is currently […]

Read More

June 27th, 2018

Professor Bruce Neal

Bruce Neal is a Senior Director at The George Institute for Global Health; Professor of Medicine, UNSW Sydney; and Chair of the Australian Division of World Action on Salt and Health. Dr. Neal is a UK-trained physician who has 20 years research experience in the clinical, epidemiological, and public health fields with a focus on […]

Read More

June 27th, 2018

Lee Schwartzberg, MD, FACP

Primary research interests include breast cancer, supportive care and developmental therapeutics. Recently involved with genomic profiling of advanced cancer. Interested in visionary approaches to clinical research and oncology science. Divides his time between individual patients in the clinic and conducting clinical research trials and programmatic development.

Read More

June 27th, 2018

Ari VanderWalde, MD, MPH, FACP

Dr. Ari VanderWalde is an internationally recognized researcher providing expertise in oncology clinical trials with a focus on immune therapies in solid tumors and melanoma. He has worked in the pharmaceutical industry helping lead the approval of a new compound in Melanoma. Along with this experience, he also works at a premier cancer research institute […]

Read More

June 27th, 2018

Mustapha “Staph” Leavenworth Bakali, MSc

Staph is the President and Chief Executive Officer of George Health Enterprises. Previously, Staph was President and Chief Operating Officer of the Clinton Health Access Initiative (CHAI). Staph has close to 30 years of senior executive and board-level experience, leading, growing, and transforming global pharmaceutical, biotechnology and not-for profit organisations, from start-ups to large, complex […]

Read More

June 27th, 2018

Tim Regan

Tim is the current COO and CFO of The George Institute for Global Health. He has extensive experience in the construction, property and services industries, including as former COO of top 50 ASX-listed Mirvac Group, CEO of TJS Services, Commercial Manager for the Sydney Organizing Committee for the Olympic Games and Senior Manager at PricewaterhouseCoopers. […]

Read More

June 27th, 2018

Professor Stephen MacMahon AO, DSc, FAA, FMedSci, FACC

Stephen is a founder of the George Institute for Global Health and an architect of its global expansion. He is Principal Director of the George Institute and also holds professorial appointments in medicine at UNSW Sydney and the University of Oxford (UK), where he holds the position Oxford Martin Senior Fellow. He is an international […]

Read More

June 27th, 2018

Vlado Perkovic, MBBS, PhD, FRACP, FASN

Vlado Perkovic is Dean of Medicine and Scientia Professor at UNSW, a Professorial Fellow at The George Institute, Australia, and a Staff Specialist in Nephrology at the Royal North Shore Hospital. His research focus is in clinical trials and epidemiology, in particular in preventing the progression of kidney disease and its complications. He leads several major […]

Read More

June 27th, 2018

David Wheeler

David is Professor of Kidney Medicine at University College London, UK and Honorary Consultant Nephrologist at the Royal Free London NHS Foundation Trust. He is a clinician scientist interested in the complications of chronic kidney disease, specifically those that increase the burden of cardiovascular disease and/or accelerate progression of kidney failure. He has participated in […]

Read More

September 11th, 2019

Roberto Pecoits-Filho, MD, PhD, FACP, FASN

Dr. Roberto Pecoits-Filho is currently a Senior Research Scientist, Arbor Research Collaborative for Health in the USA and a full professor at the School of Medicine, Catholic University of Paraná, where he was the director of the PhD and Masters Programs in Health Sciences, Chief of Nephrology and co-founder of the Academic Clinical Research Organization […]

Read More

September 24th, 2019

Jason C. Chandler

Specializes in medical oncology, hematology and blood cancers. Interested in research and immunology. Committed to providing patients with access to early-stage clinical trials. In partnership with Methodist Healthcare, facilitated FDA approval for lifesaving CAR T therapy in 2019.

Read More

November 2nd, 2019

Johan Sundström

Johan Sundström is a Professor of Epidemiology at Uppsala University, Conjoint Professor at The George Institute of Global Health, University of New South Wales and a clinical specialist in internal medicine and cardiology at the Department of Cardiology of Uppsala University Hospital. He heads the university’s Clinical Epidemiology research group. Johan’s passion is using big […]

Read More

November 2nd, 2019

Professor Ralph V. Boccia

Board certified in both hematology and oncology. Has a research interest in cancers of the blood and blood-forming tissues as well as solid tumors, such as those seen in bladder cancer. Conducts research in exploring the latest advances colorectal cancer treatment. Offers individualized care to patients with focus on multi-modal treatment regimens.

Read More

February 22nd, 2020

Adrian Liew

Dr. Adrian Liew is a Senior Consultant Nephrologist and Director of The Kidney and Transplant Practice at Mount Elizabeth Novena Hospital in Singapore. He was the founding Chief of Nephrology at the Department of Renal Medicine in Tan Tock Seng Hospital, Singapore, and was an Associate Professor of Medicine, in charge of the Renal Medicine […]

Read More

March 14th, 2020

Professor Alta Schutte

Alta (Aletta E.) Schutte, Ph.D. is Principal Theme Lead of Cardiac, Vascular and Metabolic Medicine in the Faculty of Medicine at the University of New South Wales, Sydney, Australia and Professorial Fellow at the George Institute for Global Health. She has extensive experience in working in the field of hypertension and cardiovascular disease within Africa […]

Read More

March 31st, 2020

Timothy Pluard

Specializes in offering comprehensive care including advanced genomic and immunotherapy treatments to women with metastatic breast cancer. Advises patients on participating in clinical trials for leading-edge treatments. Emphasizes the importance of in-depth communication with patients taking a fully holistic approach to their treatment options.

Read More

May 19th, 2020

David Vaux

David Vaux is Chairman of Arcadia Health Care Pty Limited, which manages and operates a private rehabilitation and medical hospital in Warriewood, Sydney. He is a fellow of the Australian Institute of Directors and serves as Chairman of Langston Holdings Pty Ltd, a family office investment company. He was the Founding Chairman of GenesisCare, Australia’s […]

Read More

August 29th, 2020

required
required
required
required
I wish to subscribe to George Clinical communications.
required

Add George Clinical to your network